Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Enteropathy-Associated T-Cell Lymphoma × Everolimus × 30 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 3 Breast Neoplasms 3 Tuberous Sclerosis 2 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Adenoma, Islet Cell 2 von Hippel-Lindau Disease 1 Unilateral Breast Neoplasms 1 Seizures 1 Recurrence 1 Myelodysplastic Syndromes 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Leukemia, Myeloid, Acute 1 Glioma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoid Tumor 1 Angiomyolipoma 1 Advanced Lung Neuroendocrine Tumor 1 Advanced Breast Cancer 1

Interventions

Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 tazemetostat 1 etoposide phosphate 1 duvelisib 1 Prednisolone 1 Melphalan 1 Cytarabine 1 Carmustine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡